{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:38:42Z","timestamp":1746319122319,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioPsychoSocial Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ethyl loflazepate (EL) is a benzodiazepine derivative that has been reported to activate the gustatory cortex. Our department routinely uses EL as a first-line treatment for idiopathic and psychogenic taste disorders, although little has been reported in the literature with respect to patient outcomes, so we conducted a retrospective study examining its safety and efficacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between 2008 and 2020, 49 patients (14 males and 35 females; mean age, 62.1\u2009years) were diagnosed with taste disorders and received EL as their only treatment for &gt;\u200914\u2009days. Severity of taste disorder was evaluated using the paper disc method by Sakai et al., and treatment efficacy was evaluated using the Visual Analog Scale, wherein patients gave subjective ratings for their symptoms (reductions by &gt;\u200950% after administration of EL for 4\u2009weeks were defined as improvements).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Results showed that the improvement rates for patients with idiopathic and psychogenic taste disorders were 55 and 70%, respectively. Additionally, the majority (78%) improved within 2\u2009weeks, and side effects were mild (seven cases with drowsiness and one case with dizziness).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We conclude that EL is an appropriate first-line medication for patients with idiopathic and psychogenic taste disorders.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13030-022-00246-1","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T07:04:10Z","timestamp":1659942250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ethyl loflazepate as a treatment for patients with idiopathic and psychogenic taste disorder"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3276-0154","authenticated-orcid":false,"given":"Ken-ichiro","family":"Sakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Hato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Iori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritaka","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhisa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"246_CR1","first-page":"50","volume":"20","author":"T Akira","year":"2005","unstructured":"Akira T, Naoki I, Masazumi S, Hiromasa T, Toshihiro K. The efficacy of co-administration of fluvoxamine and loflazepate ethyl for oral psychosomatic patients. Jpn J Psychosom Dent. 2005;20:50\u20134.","journal-title":"Jpn J Psychosom Dent"},{"issue":"1","key":"246_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/odi.13226PMID31705718","volume":"26","author":"D Paudel","year":"2020","unstructured":"Paudel D, Utsunomiya M, Yoshida K, Giri S, Uehara O, Matsuoka H, et al. Pharmacotherapy in relieving the symptoms of burning mouth syndrome: a 1-year follow-up study. Oral Dis. 2020;26(1):193\u20139. https:\/\/doi.org\/10.1111\/odi.13226PMID31705718.","journal-title":"Oral Dis"},{"issue":"4","key":"246_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/lary.22490PMID22344742","volume":"122","author":"SM Heckmann","year":"2012","unstructured":"Heckmann SM, Kirchner E, Grushka M, Wichmann MG, Hummel T. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope. 2012;122(4):813\u20136. https:\/\/doi.org\/10.1002\/lary.22490PMID22344742.","journal-title":"Laryngoscope"},{"issue":"1\u20132","key":"246_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0166-4328(01)00461-2PMID12191798","volume":"134","author":"T Shimura","year":"2002","unstructured":"Shimura T, Kamada Y, Yamamoto T. Ventral tegmental lesions reduce overconsumption of normally preferred taste fluid in rats. Behav Brain Res. 2002;134(1\u20132):123\u201330. https:\/\/doi.org\/10.1016\/s0166-4328(01)00461-2PMID12191798.","journal-title":"Behav Brain Res"},{"key":"246_CR5","first-page":"247","volume":"62","author":"Y Yutaka","year":"2013","unstructured":"Yutaka Y, Ken-Ichiro S, Jun S, Manabu O, Hironobu H, Atsushi M, et al. Clinical study of 210 cases of taste disorder. J Jpn Stomatol Soc. 2013;62:247\u201353.","journal-title":"J Jpn Stomatol Soc"},{"key":"246_CR6","first-page":"23","volume":"21","author":"T Hiromasa","year":"2006","unstructured":"Hiromasa T, Akira T, Naoki I, Masazumi S, Aki M, Toshihiro K. Efficacy of ethyl loflazepate for phantogeusia \u2013 a case study. Jpn J Psychosom Dent. 2006;21:23\u20136.","journal-title":"Jpn J Psychosom Dent"},{"key":"246_CR7","first-page":"129","volume":"546","author":"S Fumitaka","year":"2002","unstructured":"Fumitaka S, Shinya Y, Sohei E, Hiroshi T. Double-blind, pracebo controlled trial of zinc picolinate for taste disorders. Acta Otolaryngol. 2002;546:129\u201333.","journal-title":"Acta Otolaryngol"},{"key":"246_CR8","unstructured":"Paolo MS, Robert MR. Harrison\u2019s principles internal medicine. 20th ed,;McGraw-Hill Education \/ Medical,ISBN 978\u2013123\u2013964-403-0; 2018."},{"issue":"4","key":"246_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1017\/s0033291700009934PMID3078045","volume":"18","author":"HM McCormack","year":"1988","unstructured":"McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18(4):1007\u201319. https:\/\/doi.org\/10.1017\/s0033291700009934PMID3078045.","journal-title":"Psychol Med"},{"key":"246_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0385-8146(86)80019-0","volume":"13","author":"T Hiroshi","year":"1986","unstructured":"Hiroshi T, Minoru I, Yukio O. Basis and practice of clinical taste examination. Auris Nasus Larynx. 1986;13:1\u20139.","journal-title":"Auris Nasus Larynx"},{"issue":"10","key":"246_CR11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/00016480802552550PMID19037756","volume":"129","author":"M Sakagami","year":"2009","unstructured":"Sakagami M, Ikeda M, Tomita H, Ikui A, Aiba T, Takeda N, et al. A zinc-containing compound, polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study. Acta Otolaryngol. 2009;129(10):1115\u201320. https:\/\/doi.org\/10.1080\/00016480802552550PMID19037756.","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"246_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00000441-197611000-00006PMID797259","volume":"272","author":"RI Henkin","year":"1976","unstructured":"Henkin RI, Schecter PJ, Friedewald WT, Demets DL, Raff M. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci. 1976;272(3):285\u201399. https:\/\/doi.org\/10.1097\/00000441-197611000-00006PMID797259.","journal-title":"Am J Med Sci"},{"issue":"2","key":"246_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0385-8146(12)80219-7","volume":"18","author":"S Yoshida","year":"1991","unstructured":"Yoshida S, Endo S, Tomita H. A double-blind study of the therapeutic efficacy of zinc gluconate on taste disorder. Auris Nasus Larynx. 1991;18(2):153\u201361. https:\/\/doi.org\/10.1016\/S0385-8146(12)80219-7.","journal-title":"Auris Nasus Larynx"},{"issue":"Suppl 5","key":"246_CR14","first-page":"7","volume":"65","author":"G Chouinard","year":"2004","unstructured":"Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry. 2004;65(Suppl 5):7\u201312 PMID 15078112.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 2","key":"246_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4088\/JCP.v66n0104PMID15762817","volume":"66","author":"CP O\u2019Brien","year":"2005","unstructured":"O\u2019Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66(Suppl 2):28\u201333. https:\/\/doi.org\/10.4088\/JCP.v66n0104PMID15762817.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"246_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/00016480510040173PMID16353402","volume":"125","author":"M Ikeda","year":"2005","unstructured":"Ikeda M, Aiba T, Ikui A, Inokuchi A, Kurono Y, Sakagami M, et al. Taste disorders: a survey of the examination methods and treatments used in Japan. Acta Otolaryngol. 2005;125(11):1203\u201310. https:\/\/doi.org\/10.1080\/00016480510040173PMID16353402.","journal-title":"Acta Otolaryngol"},{"key":"246_CR17","unstructured":"Akiko S, Tomomi N, Hideki O, Emi M, Atsushi N, Masanori U et al. Clinical analysis of 1059 patients with taste disorders. Nippon Jibii."},{"issue":"10","key":"246_CR18","first-page":"1573","volume":"35","author":"JP Chambon","year":"1985","unstructured":"Chambon JP, Perio A, Demarne H, Hallot A, Dantzer R, Roncucci R, et al. Ethyl loflazepate: A prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities. Arzneim Forsch. 1985;35(10):1573\u20137 PMID 2866771.","journal-title":"Arzneim Forsch"},{"key":"246_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1744-859X-9-37","volume":"9","author":"F Goro","year":"2010","unstructured":"Goro F, Tasuku H, Yukihiko S, Tadashi H, Hiroyuki W, Mihisa F, et al. Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects. Ann General Psychiatry. 2010;9:37. https:\/\/doi.org\/10.1186\/1744-859X-9-37.","journal-title":"Ann General Psychiatry"}],"container-title":["BioPsychoSocial Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13030-022-00246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13030-022-00246-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13030-022-00246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T07:08:49Z","timestamp":1659942529000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpsmedicine.biomedcentral.com\/articles\/10.1186\/s13030-022-00246-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["246"],"URL":"https:\/\/doi.org\/10.1186\/s13030-022-00246-1","relation":{},"ISSN":["1751-0759"],"issn-type":[{"type":"electronic","value":"1751-0759"}],"subject":[],"published":{"date-parts":[[2022,8,8]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted with the approval of the Hokkaido University Hospital Independent Clinical Research Review Committee (Approval No. 018\u20130381) and waived the requirement for informed consent owing to the retrospective design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}